Physician profile
Martin Williams
NPI 1902863798
$1,826.26
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,392 · 2020: $388 · 2021: $45.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $375.50 | 2019-2021 | |
| Glaxosmithkline, LLC. | $194.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.05 | 2019-2021 | |
| Astellas Pharma US INC | $157.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $149.17 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $138.73 | 2019 | |
| Novo Nordisk INC | $95.11 | 2019-2020 | |
| Amarin Pharma, INC. | $80.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $74.89 | 2019-2020 | |
| Amgen INC. | $69.60 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $59.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $58.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.90 | 2019 | |
| Genentech USA, INC. | $34.66 | 2019-2020 | |
| Sanofi Pasteur INC. | $29.93 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $18.37 | 2019 | |
| Radius Health, INC. | $17.93 | 2019 | |
| Qiagen, LLC | $15.94 | 2019 | |
| Daiichi Sankyo INC. | $15.60 | 2019 | |
| Pfizer INC. | $12.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.